Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/12/2012WO2011159870A9 Methods and compounds for the preparation of fluorine-labeled deoxy-fty720
04/12/2012WO2011159471A3 Linked purine pterin hppk inhibitors useful as antibacterial agents
04/12/2012WO2011156479A3 Trkb agonists and methods of use
04/12/2012WO2011154442A3 Process for the preparation of o/w emulsions
04/12/2012WO2011153323A8 Compositions and methods directed to treating liver fibrosis
04/12/2012WO2011150030A9 Method to alleviate diabetic end stage renal disease
04/12/2012WO2011149950A3 Bicyclic heteroaryl kinase inhibitors and methods of use
04/12/2012WO2011146621A9 Treatment of clostridium difficile infection in patients undergoing antibiotic therapy
04/12/2012WO2011139709A9 Methods of treating retroviral infections and related dosage regimes
04/12/2012WO2011137427A9 Compositions and methods for treating pulmonary conditions
04/12/2012WO2011136561A3 Composition for the treatment of vitiligo, containing serotonin as an active ingredient
04/12/2012WO2011135581A3 Pharmaceutical compositions of dronedarone
04/12/2012WO2011133424A3 Genetic amplification of iqgap1 in cancer
04/12/2012WO2011133210A3 A method treating breast cancer
04/12/2012WO2011133039A3 Novel conjugates of cc-1065 analogs and bifunctional linkers
04/12/2012WO2011132966A3 Transdermal absorption preparation
04/12/2012WO2011130615A3 Preparation of lacosamide
04/12/2012WO2011128914A3 Extended release pharmaceutical compositions of pramipexole
04/12/2012WO2011127291A3 Compositions and methods for the treatment of a neoplasia
04/12/2012WO2011124953A3 Controlled release pharmaceutical compositions of tapentadol
04/12/2012WO2011106478A3 Apixaban formulations
04/12/2012WO2011102702A3 Process for the preparation of oral solid dosage forms comprising valsartan
04/12/2012WO2011083490A3 Stable veterinary composition for enhanced phosphorous uptake
04/12/2012WO2011082281A3 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
04/12/2012WO2011080346A3 Pellets and microparticles of pravastatin sodium and a process of making them
04/12/2012WO2011077245A3 Composition comprising an oxysterol modulator and a cd25 - depleting monoclonal antibody for treating cancer
04/12/2012WO2011077239A3 Slow release pharmaceutical compositions of iloperidone
04/12/2012WO2011071853A3 Parenteral formulation of clopidogrel
04/12/2012WO2011060887A3 Method for production of f-18 labeled glutamic acid derivatives
04/12/2012WO2011043788A8 Daptomycin for multiple sclerosis
04/12/2012WO2011008931A3 Arylpyrimidine compounds and combination therapy comprising same for treating cystic fibrosis & related disorders
04/12/2012WO2010120275A3 Menthol-derivative compounds and use thereof as oral and systemic active agents
04/12/2012WO2007103111A8 Antiviral drugs for treatment of arenavirus infection
04/12/2012US20120090043 Targets for retrovirus associated diseases
04/12/2012US20120089541 Biomarkers and methods of treatment
04/12/2012US20120089084 Wound healing device
04/12/2012US20120088911 Novel carboxylic acid derivatives, their preparation and use
04/12/2012US20120088841 Composition and a method of treating cns disorders and hyperpigmentation
04/12/2012US20120088840 Novel use of panduratin derivative or boesenbergia pandurata extract
04/12/2012US20120088839 Composition for regulating cellular senescence comprising [n-2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide
04/12/2012US20120088838 Methods for maintaining effective plasma concentrations of a pharmaceutical
04/12/2012US20120088837 Tetralin and indane derivatives and uses thereof
04/12/2012US20120088836 Use of a jasmonic acid compound for treating greasy skin
04/12/2012US20120088835 Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
04/12/2012US20120088834 Crystalline forms of a 3-carboxypropyl-aminotetralin compound
04/12/2012US20120088833 Modified amino acid for the inhibition of platelet aggregation
04/12/2012US20120088832 Anti-Adhesive Barrier Membrane Using Alginate and Hyaluronic Acid for Biomedical Applications
04/12/2012US20120088831 Thraustochytrids, Fatty Acid Compositions, and Methods of Making and Uses Thereof
04/12/2012US20120088830 Satiety-inducing composition
04/12/2012US20120088829 Formulations of Ubiquinol and Resveratrol Esters
04/12/2012US20120088827 Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting The Nuclear Factor-Kappa (B) - (NF-KB)
04/12/2012US20120088826 Process for production of optically active amine derivatives
04/12/2012US20120088825 Compounds with activity at estrogen receptors
04/12/2012US20120088824 Dosage unit comprising a prostaglandin analog for treating constipation
04/12/2012US20120088823 Composition and method for scalp and hair treatment
04/12/2012US20120088822 Low-dose doxepin for treatment of sleep disorders in elderly patients
04/12/2012US20120088821 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
04/12/2012US20120088820 Pharmaceutical composition for treating and preventing diseases related to joints and connective tissue
04/12/2012US20120088819 Method for enhancing expression of recombinant protein
04/12/2012US20120088818 Conformation-selective nucleic acid inhibitors of ampa glutamate receptors
04/12/2012US20120088817 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
04/12/2012US20120088816 Head-And-Neck Tumor Proliferation Inhibitor
04/12/2012US20120088815 Modified Oligonucleotide and Its Preparation and Application
04/12/2012US20120088814 Methods of modulating an immune response to a viral infection
04/12/2012US20120088813 Anti viral therapy
04/12/2012US20120088812 Compositions for promoting epigenetic dna demethylation and methods of use therefore
04/12/2012US20120088811 Method for the treatment of acute myeloid leukemia
04/12/2012US20120088810 Thioxanthone ring system derivatives
04/12/2012US20120088809 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
04/12/2012US20120088808 Crystal forms of saxagliptin
04/12/2012US20120088807 Interlaced method for treating cancer or a precancerous condition
04/12/2012US20120088805 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
04/12/2012US20120088804 Clevidipine emulsion formulations containing antimicrobial agents
04/12/2012US20120088802 Tricyclic compounds, compositions and methods
04/12/2012US20120088801 Pirfenidone Therapy and Inducers of Cytochrome P450
04/12/2012US20120088800 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS
04/12/2012US20120088799 Serotonin reuptake inhibitors
04/12/2012US20120088798 Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors
04/12/2012US20120088797 1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
04/12/2012US20120088796 Compounds that inhibit (block) bitter taste in composition and use thereof
04/12/2012US20120088795 Factor xa inhibitors
04/12/2012US20120088794 Aminotetralin compounds as mu opioid receptor antagonists
04/12/2012US20120088793 Bicyclic Compounds and Methods of Making and Using Same
04/12/2012US20120088792 Pyridin-2-YL Methylamine Derivatives for Treating Opiate Dependence
04/12/2012US20120088791 Amidobipiperidinecarboxylate m1 allosteric agonists, analogs and derivatives thereof, and methods of making and using same
04/12/2012US20120088790 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
04/12/2012US20120088789 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
04/12/2012US20120088788 Substituted imidazoles as bombesin receptor subtype-3 modulators
04/12/2012US20120088787 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
04/12/2012US20120088786 Immediate release pharmaceutical compositions comprising oxycodone and naloxone
04/12/2012US20120088785 New uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute delirium
04/12/2012US20120088784 Substituted Aromatic Compounds and Pharmaceutical Uses thereof
04/12/2012US20120088783 Chroman derivatives
04/12/2012US20120088782 Lpa receptor antagonist
04/12/2012US20120088781 Famciclovir for the Treatment of Recurrent genital Herpes Labialis with a one day application
04/12/2012US20120088780 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/12/2012US20120088779 Heterocyclic sulfonamides
04/12/2012US20120088778 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
04/12/2012US20120088777 5-ht1a receptor subtype agonist
04/12/2012US20120088776 Treatment of mammalian disorders mediated by alpha-anhydrase isoforms
1 ... 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 ... 7860